What is type 2 diabetes?

Medicine

Volumn 38, Issue 11, 2010, Pages 597-601

  Smushkin, Galina ^a   Vella, Adrian ^a  

^a MAYO CLINIC   (United States)

Author keywords

incretin hormones; insulin action; insulin secretion; pre diabetes; type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CORTICOSTEROID; CYCLOSPORIN; GLUCOSE; INSULIN; INTERFERON; METFORMIN; NICOTINIC ACID; OLANZAPINE; PENTAMIDINE; PROTEINASE INHIBITOR; RAPAMYCIN; RISPERIDONE; TACROLIMUS; THIAZIDE DIURETIC AGENT;

AMPUTATION; BARIATRIC SURGERY; BLINDNESS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; HYPERGLYCEMIA; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY DISEASE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET CELL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 77958595471     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2010.08.008     Document Type: Review

References (42)

1. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1997 1183 1197
2. E.A. Gale Declassifying diabetes Diabetologia 49 2006 1989 1995
3. P. Shah, A. Vella, and A. Basu Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia Diabetes 52 2003 38 42
4. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 2009 1327 1334
5. M.B. Davidson, D.L. Schriger, A.L. Peters, and B. Lorber Glycosylated hemoglobin as a diagnostic test for type 2 diabetes mellitus JAMA 283 2000 606 607
6. S.F. Dinneen, D. Maldonado 3rd, and C.L. Leibson Effects of changing diagnostic criteria on the risk of developing diabetes Diabetes Care 21 1998 1408 1413
7. P. Shah, A. Vella, A. Basu, R. Basu, W.F. Schwenk, and R.A. Rizza Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus J Clin Endocrinol Metab 85 2000 4053 4059
8. M.R. Hayden, and J.R. Sowers Isletopathy in Type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress Antioxid Redox Signal 9 2007 891 910
9. N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J.D. Veldhuis, and O. Schmitz Pulsatile insulin secretion: detection, regulation, and role in diabetes Diabetes 51 suppl 1 2002 S245 254
10. S. O'Rahilly, R.C. Turner, and D.R. Matthews Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes N Engl J Med 318 1988 1225 1230
11. J.C. Florez, K.A. Jablonski, and N. Bayley TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program N Engl J Med 355 2006 241 250
12. G. Bock, C. Dalla Man, and M. Campioni Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance Diabetes 55 2006 3536 3549
13. G. Smushkin, and A. Vella Genetics of type 2 diabetes Curr Opin Clin Nutr Metab Care 13 2010 471 477
14. J. Tonelli, P. Kishore, D.E. Lee, and M. Hawkins The regulation of glucose effectiveness: how glucose modulates its own production Curr Opin Clin Nutr Metab Care 8 2005 450 456
15. A. Basu, A. Caumo, and F. Bettini Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol Diabetes 46 1997 421 432
16. X. Chen, N. Iqbal, and G. Boden The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects J Clin Invest 103 1999 365 372
17. T. Vilsboll, T. Krarup, C.F. Deacon, S. Madsbad, and J.J. Holst Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients Diabetes 50 2001 609 613
18. M. Laakso, J. Zilinskaite, and T. Hansen Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study Diabetologia 51 2008 502 511
19. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 854 865
20. R.C. Turner, C.A. Cull, V. Frighi, and R.R. Holman Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group JAMA 281 1999 2005 2012
21. S.E. Kahn, S.M. Haffner, and M.A. Heise Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 2006 2427 2443
22. W.C. Knowler, E. Barrett-Connor, and S.E. Fowler Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
23. K.F. Eriksson, and F. Lindgarde Prevention of type 2 (non-insulin- dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study Diabetologia 34 1991 891 898
24. D.H. Ryan, M.A. Espeland, and G.D. Foster Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes Control Clin Trials 24 2003 610 628
25. X. Pi-Sunyer, G. Blackburn, and F.L. Brancati Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial Diabetes Care 30 2007 1374 1383
26. A.H. Xiang, R.K. Peters, and S.L. Kjos Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes Diabetes 55 2006 517 522
27. T.A. Buchanan, A.H. Xiang, and R.K. Peters Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women Diabetes 51 2002 2796 2803
28. J. Weng, Y. Li, and W. Xu Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial Lancet 371 2008 1753 1760
29. G.E. Umpierrez, D. Smiley, and A.E. Kitabchi Narrative review: ketosis-prone type 2 diabetes mellitus Ann Intern Med 144 2006 350 357
30. F. Rubino, P.R. Schauer, L.M. Kaplan, and D.E. Cummings Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action Annu Rev Med 61 2010 393 411
31. M.C. Gulliford, J. Charlton, and R. Latinovic Risk of diabetes associated with prescribed glucocorticoids in a large population Diabetes Care 29 2006 2728 2729
32. R.A. Rizza, L.J. Mandarino, and J.E. Gerich Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action J Clin Endocrinol Metab 54 1982 131 138
33. A.J. Scheen, and M.A. De Hert Abnormal glucose metabolism in patients treated with antipsychotics Diabetes Metab 33 2007 169 175
34. D.E. Johnson, H. Yamazaki, and K.M. Ward Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia Diabetes 54 2005 1552 1558
35. K.A. Bodziak, and D.E. Hricik New-onset diabetes mellitus after solid organ transplantation Transpl Int 22 2009 519 530
36. T. Yagisawa, K. Takahashi, S. Teraoka, H. Toma, T. Agishi, and K. Ota Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats Transplant Proc 19 1987 1801 1803
37. J.H. Nielsen, T. Mandrup-Poulsen, and J. Nerup Direct effects of cyclosporin A on human pancreatic beta-cells Diabetes 35 1986 1049 1052
38. B.L. Kasiske, J.J. Snyder, D. Gilbertson, and A.J. Matas Diabetes mellitus after kidney transplantation in the United States Am J Transplant 3 2003 178 185
39. H.J. Woerle, P.R. Mariuz, and C. Meyer Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens Diabetes 52 2003 918 925
40. E. Resmini, F. Minuto, A. Colao, and D. Ferone Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities Acta Diabetol 46 2009 85 95
41. G. Stenstrom, L. Sjostrom, and U. Smith Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma Acta Endocrinol (Copenh) 106 1984 511-15
42. S. Umeda, K. Ito, and Y. Tsujita Severe hypoglycemia after resection of adrenal pheochromocytoma: a case report Hinyokika Kiyo 55 2009 123 127